Cell therapy weekly: FDA approves glycogen storage disease type 1a gene therapy
Cell therapy weekly: FDA approves glycogen storage disease type 1a gene therapy RegMedNet
2026
FDA Approves Pasatru | PharmExec
FDA Approves Pasatru | PharmExec Pharmaceutical Executive
FDA Approves Glenmark’s Generic Fluticasone Propionate Nasal Spray
FDA Approves Glenmark’s Generic Fluticasone Propionate Nasal Spray HCPLive
Recon: FDA approves Ultragenyx gene therapy for glycogen storage disorder; Overton faces confirmation challenges
Recon: FDA approves Ultragenyx gene therapy for glycogen storage disorder; Overton faces confirmation challenges RAPS